logo
Despite profit dip, Bursa Malaysia's IPO growth attracts Singapore firms' interest

Despite profit dip, Bursa Malaysia's IPO growth attracts Singapore firms' interest

Business Times2 days ago
[KUALA LUMPUR] Bursa Malaysia is emerging as a key listing venue for Singapore-based companies, even as the bourse operator reported a 19.3 per cent year-on-year (yoy) drop in net profit to RM125.5 million (S$37.8 million) for the first half of 2025.
The exchange is seeing rising interest from Singapore companies seeking secondary or dual listings, buoyed by its strong performance in the Asean initial public offering (IPO) market.
These developments come despite weaker overall trading volumes that have weighed on Bursa's financial performance.
Fad'l Mohamed, chief executive officer of Bursa Malaysia, told a results briefing on Tuesday (Jul 29): 'We are seeing more interest from Singapore companies. One of them is UMS Integration , which will be listed on the main market... this Friday.'
The high-precision engineering and manufacturing company is pursuing a secondary listing on Bursa Malaysia through an introductory route to broaden its investor base and boost stock liquidity. No new shares will be issued; instead, initial liquidity will be supported by a market-making arrangement involving shares borrowed from CEO Andy Luong.
The listing's reference price will be pegged to UMS Integration's Jul 31 closing price on the Singapore Exchange, ahead of its debut on Bursa Malaysia on Aug 1.
A NEWSLETTER FOR YOU
Friday, 8.30 am Asean Business
Business insights centering on South-east Asia's fast-growing economies.
Sign Up
Sign Up
Meanwhile, Oiltek International and Q&M Dental Group – also Singapore-based companies – have proposed secondary listings on Bursa as well.
Precision manufacturing and assembly solutions provider Grand Venture Technology was also pursuing a secondary listing on Bursa's main market but halted the plan in June , despite receiving approval from Securities Commission Malaysia approval months earlier.
'Bursa Malaysia continued to top other bourses in Asean in the first half of 2025 across three key metrics of IPOs: number of IPOs, total IPO market capitalisation, and total IPO funds raised,' noted Fad'l.
The exchange hosted 32 IPOs in H1, raising RM4 billion and posting a total IPO market capitalisation of RM17.4 billion. This compares with 21 IPOs and RM2.2 billion raised during the same period in 2024.
According to Deloitte, Bursa Malaysia captured over 67 per cent of the IPO proceeds in South-east Asia , which overall had 53 IPOs and raised more than US$1.4 billion in H1 2025.
'We have a healthy pipeline of IPOs in the coming months and are well on track to achieve our annual target of 60 IPOs and RM40.2 billion in total market capitalisation by end-2025,' Fad'l added.
Profit squeeze from lower trading activity
Despite the strong IPO pipeline, Bursa Malaysia's financial results were hit by a downturn in trading activity amid global market headwinds. H1 revenue fell 7.8 per cent to RM357 million, dragged by a 15.5 per cent drop in trading revenue to RM213 million.
Second-quarter net profit fell 29 per cent yoy to RM57.1 million, while revenue declined 13.9 per cent to RM172.6 million.
'Global developments, including the United States' ongoing tariff negotiations with its trading partners and persistent geopolitical tensions, impacted market sentiment and weighed on equity markets,' Fad'l explained.
Securities market trading revenue dropped nearly 24 per cent to RM146.4 million, with average daily trading value down 24.8 per cent at RM2.5 billion. Trading velocity also fell to 32 per cent from 42 per cent a year earlier.
Nevertheless, Bursa Malaysia declared an interim dividend of 14 sen per share, translating to a total payout of RM113.3 million, or 90.3 per cent of net profit – offering a yield of 3.7 per cent.
Optimism for second half
Bursa Malaysia's financial results for H1 2025 were impacted by a downturn in trading activity. PHOTO: BT FILE
Despite the current conditions, Fad'l remains optimistic, anticipating improved market sentiment in the coming quarters.
'Funds are currently sitting on cash, but we anticipate they will start deploying it, capitalising on forward-looking catalysts and expected growth opportunities in 2026,' he said.
He noted that the second half of the year will be the prime time for fund managers to capture the upside of 2026. 'With this elevated cash being injected into the market, it's set to propel the average daily trading value.'
Citing analysts' estimates, he believes that the average daily trading value will increase to RM2.6 billion in H2.
Therefore, Bursa is maintaining its 2025 profit before tax target at the RM369 million to RM408 million range, a key performance indicator.
Derivatives, Islamic and data segments show growth
Bursa's derivatives market revenue rose 8.1 per cent to RM56.1 million in H1, supported by active trading in crude palm oil futures. The exchange also relaunched its Single Stock Futures contracts in March with new specifications to widen its investor base.
Revenue from the Islamic capital market jumped 23 per cent year on year to RM11 million, while non-trading revenue – covering listing, issuer and depository services – increased by 7.6 per cent to RM130.5 million.
Data business revenue grew 6.4 per cent to RM40.5 million, driven by expanding licensing subscriptions and rising demand for high-quality, actionable financial and sustainability data.
As at Jun 30, Bursa Malaysia's total market capitalisation stood at RM1.9 trillion, down 6.1 per cent from a year earlier.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Perennial Holdings enters partnership to establish hospital in Shanghai with 500 million yuan investment
Perennial Holdings enters partnership to establish hospital in Shanghai with 500 million yuan investment

Business Times

time14 minutes ago

  • Business Times

Perennial Holdings enters partnership to establish hospital in Shanghai with 500 million yuan investment

[SINGAPORE] Singapore-based real estate and healthcare company Perennial Holdings announced on Thursday (Jul 31) that it has entered into a partnership with the Lujiazui Administrative Bureau of the China (Shanghai) Pilot Free Trade Zone and Shanghai Lujiazui, to establish the first wholly foreign-owned tertiary general hospital in Shanghai. Perennial General Hospital Shanghai's total investment cost is expected to amount to 500 million yuan (S$90.2 million), with a planned capacity of 500 beds. A foreign medical investment company will be incorporated in the Lujiazui District, Shanghai, to establish the hospital, said Perennial Holdings. The hospital will feature a team of medical experts from China and other countries. Aside from general medical areas such as internal medicine, surgery and health screening, it will house centres of excellence with specialisations including orthopaedics, oncology, cardiovascular diseases and otolaryngology. The healthcare company said that the hospital will be built according to international standards, integrating advanced medical equipment and technology, as well as global service standards. It will also be designed with a garden-style environment, serve as a platform for global medical exchange, and foster collaboration and sharing of clinical expertise, the group added. This move reaffirms the long-term confidence that Perennial Holdings has in China's healthcare market, said executive chairman and chief executive Pua Seck Guan. 'Shanghai is witnessing a burgeoning demand for premium and personalised medical services. The Perennial General Hospital Shanghai will leverage its strategic location to serve both local residents and expatriates in the city, and introduce innovative medical treatments and packages for high-net-worth international clients to support the growth of Shanghai's medical tourism sector,' he added. Perennial Holdings has five healthcare-centric transit-oriented developments typically integrating medical care, eldercare and hospitality components, connected to high-speed railway stations located in Tianjin, Kunming, Chengdu, Xi'an and Chongqing in China. It manages and operates over 25,000 beds in medical and eldercare facilities, comprising about 16,000 operational beds and over 9,000 beds in the pipeline, across 15 cities in China and Singapore. It is set to launch a private integrated rehabilitation and traditional Chinese medicine sanctuary, the group said.

Accor warns of bigger-than-expected 2025 FX impact
Accor warns of bigger-than-expected 2025 FX impact

Business Times

time14 minutes ago

  • Business Times

Accor warns of bigger-than-expected 2025 FX impact

[PARIS] Accor, Europe's biggest hotel group, on Thursday (Jul 31) forecast a larger-than-expected impact from adverse exchange movements this financial year, causing its shares to drop more than 12 per cent in early trading. While the French-based company reported a 9.4 per cent rise in earnings before interest, taxes, depreciation and amortisation (Ebitda) to 552 million euros (S$818.4 million), ahead of market expectations, it warned it would be adversely affected by around 60 million euros on the basis of expected exchange rates. 'Accor is now guiding for a negative impact of circa 5 per cent from FX, against a consensus of approximately 2 per cent', JPMorgan said in a note, warning that would 'weigh on the shares today'. Accor's revenue per available room (RevPAR), one of the industry's main performance indicators, fell below the consensus of 4.7 per cent to 4.1 per cent for the second quarter. Despite that, the operator of brands including Ibis and Novotel, said it remained confident of hitting its medium-term growth targets. 'The momentum remains positive, despite the negative impact of exchange rate fluctuations - in particular the appreciation of the euro against the dollar,' finance chief Martine Gerow told reporters. Accor said revenue in the six months to July 31 reached 233 million euros, down from 253 million euros a year earlier. The group reiterated its outlook for 2025, including RevPAR growth of between 3 per cent and 4 per cent. REUTERS

Singapore's Perennial setting up 500 million yuan general hospital in Shanghai
Singapore's Perennial setting up 500 million yuan general hospital in Shanghai

Business Times

time14 minutes ago

  • Business Times

Singapore's Perennial setting up 500 million yuan general hospital in Shanghai

[SINGAPORE] Singapore-based real estate and healthcare company Perennial Holdings announced on Thursday (Jul 31) that it has entered into a partnership with the Lujiazui Administrative Bureau of the China (Shanghai) Pilot Free Trade Zone and Shanghai Lujiazui, to establish the first wholly foreign-owned tertiary general hospital in Shanghai. Perennial General Hospital Shanghai's total investment cost is expected to amount to 500 million yuan (S$90.2 million), with a planned capacity of 500 beds. A foreign medical investment company will be incorporated in the Lujiazui District, Shanghai, to establish the hospital, said Perennial Holdings. The hospital will feature a team of medical experts from China and other countries. Aside from general medical areas such as internal medicine, surgery and health screening, it will house centres of excellence with specialisations including orthopaedics, oncology, cardiovascular diseases and otolaryngology. The healthcare company said that the hospital will be built according to international standards, integrating advanced medical equipment and technology, as well as global service standards. It will also be designed with a garden-style environment, serve as a platform for global medical exchange, and foster collaboration and sharing of clinical expertise, the group added. This move reaffirms the long-term confidence that Perennial Holdings has in China's healthcare market, said executive chairman and chief executive Pua Seck Guan. 'Shanghai is witnessing a burgeoning demand for premium and personalised medical services. The Perennial General Hospital Shanghai will leverage its strategic location to serve both local residents and expatriates in the city, and introduce innovative medical treatments and packages for high-net-worth international clients to support the growth of Shanghai's medical tourism sector,' he added. Perennial Holdings has five healthcare-centric transit-oriented developments typically integrating medical care, eldercare and hospitality components, connected to high-speed railway stations located in Tianjin, Kunming, Chengdu, Xi'an and Chongqing in China. It manages and operates over 25,000 beds in medical and eldercare facilities, comprising about 16,000 operational beds and over 9,000 beds in the pipeline, across 15 cities in China and Singapore. It is set to launch a private integrated rehabilitation and traditional Chinese medicine sanctuary in Singapore, the group said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store